Cargando…

Drug Repurposing Applications to Overcome Male Predominance via Targeting G2/M Checkpoint in Human Esophageal Squamous Cell Carcinoma

SIMPLE SUMMARY: Sex biases in cancer incidence and cancer mortality exist in the majority of cancer types. Esophageal squamous cell carcinoma (ESCC) is a typical malignancy with higher mortality rates and worse responses to treatment in males versus females. To overcome the male predominance in ESCC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Yin, Yu, Xiao, Feng, Riyue, Li, Yang, Zhao, Yahui, Liu, Zhihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741366/ https://www.ncbi.nlm.nih.gov/pubmed/36497337 http://dx.doi.org/10.3390/cancers14235854

Ejemplares similares

RPS15 interacted with IGF2BP1 to promote esophageal squamous cell carcinoma development via recognizing m(6)A modification
por: Zhao, Yahui, et al.
Publicado: (2023)

Overcoming cancer therapeutic bottleneck by drug repurposing
por: Zhang, Zhe, et al.
Publicado: (2020)

Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing
por: Bahmad, Hisham F., et al.
Publicado: (2022)

Editorial: Adopting drug repurposing to overcome drug resistance in cancer
por: Shankar, Eswar, et al.
Publicado: (2023)

All‐Trans Retinoic Acid Promotes a Tumor Suppressive OTUD6B‐β‐TrCP‐SNAIL Axis in Esophageal Squamous Cell Carcinoma and Enhances Immunotherapy
por: Li, Lei, et al.
Publicado: (2023)

DRUG REPURPOSING—Overcoming the translational hurdles to clinical use
por: Martin, Jennifer H., et al.
Publicado: (2019)

Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing
por: El Zarif, Talal, et al.
Publicado: (2022)

A global assessment of the male predominance in esophageal adenocarcinoma
por: Xie, Shao-Hua, et al.
Publicado: (2016)

Elevated TAB182 enhances the radioresistance of esophageal squamous cell carcinoma through G2‐M checkpoint modulation
por: Cao, Yuandong, et al.
Publicado: (2021)

Overcoming obstacles to repurposing for neurodegenerative disease
por: Shineman, Diana W, et al.
Publicado: (2014)

Computational Drug Repurposing Approach to Identify Novel Inhibitors of ILK Protein for Treatment of Esophageal Squamous Cell Carcinoma
por: Liu, Juan, et al.
Publicado: (2022)

Drug Repurposing to Circumvent Immune Checkpoint Inhibitor Resistance in Cancer Immunotherapy
por: To, Kenneth K. W., et al.
Publicado: (2023)

Repurposing drugs for solid tumor treatment: focus on immune checkpoint inhibitors
por: Liu, Qingxu, et al.
Publicado: (2023)

Overcoming Resistance to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinomas
por: dos Santos, Lucas V., et al.
Publicado: (2021)

Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol
por: Olivas-Aguirre, Miguel, et al.
Publicado: (2021)

Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus
por: Mahey, Nisha, et al.
Publicado: (2021)

Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma
por: Lohse, Ines, et al.
Publicado: (2018)

Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs
por: Ezquerra-Aznárez, José Manuel, et al.
Publicado: (2021)

A drug repurposing strategy for overcoming human multiple myeloma resistance to standard-of-care treatment
por: Chroma, Katarina, et al.
Publicado: (2022)

Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics
por: Hernandez, J. Javier, et al.
Publicado: (2017)

Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities
por: Jiao, Ruidi, et al.
Publicado: (2019)

Immune Checkpoint Inhibitors in Cancer Therapy—How to Overcome Drug Resistance?
por: Lao, Yefang, et al.
Publicado: (2022)

Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi
por: Peyclit, Lucie, et al.
Publicado: (2021)

Immune checkpoint inhibitors for esophageal squamous cell carcinoma: a narrative review
por: Zhang, Wencheng, et al.
Publicado: (2020)

Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma
por: Baba, Yoshifumi, et al.
Publicado: (2020)

Virtual screening on the web for drug repurposing: a primer
por: Chen, Yu Wai, et al.
Publicado: (2021)

Squamous Predominant Teratoid Wilms’ Tumor
por: Yadav, Yogesh Kumar, et al.
Publicado: (2012)

lncRNA MALAT1 Promotes EMT Process and Cisplatin Resistance of Oral Squamous Cell Carcinoma via PI3K/AKT/m-TOR Signal Pathway
por: Wang, Ran, et al.
Publicado: (2020)

Doxazosin, a Classic Alpha 1-Adrenoceptor Antagonist, Overcomes Osimertinib Resistance in Cancer Cells via the Upregulation of Autophagy as Drug Repurposing
por: Suzuki, Shuhei, et al.
Publicado: (2020)

Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors
por: Thuru, Xavier, et al.
Publicado: (2022)

Combinations using checkpoint blockade to overcome resistance
por: Morganti, Stefania, et al.
Publicado: (2020)

Transcriptomics based multi-dimensional characterization and drug screen in esophageal squamous cell carcinoma
por: Li, Yin, et al.
Publicado: (2021)

Drug repositioning for esophageal squamous cell carcinoma
por: Bennett, Adam N., et al.
Publicado: (2022)

Deep proteome profiling promotes whole proteome characterization and drug discovery for esophageal squamous cell carcinoma
por: Liu, Wei, et al.
Publicado: (2022)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

Antifungal Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2020)

Drug repurposing in cardiology
por: van Driel, B. O., et al.
Publicado: (2020)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade
por: Xu, Lijun, et al.
Publicado: (2022)

Zika M—A Potential Viroporin: Mutational Study and Drug Repurposing
por: Tomar, Prabhat Pratap Singh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cpvqtss8dtf2l4j1leorf0752e